Nucleotide excision repair genotype and the incidence of endometrial cancer: Effect of other risk factors on the association

Gynecologic Oncology

Volumn 103, Issue 3, 2006, Pages 891-896

  Weiss, Jocelyn M ^a,b,c   Weiss, Noel S ^a,b   Ulrich, Cornelia M ^a,b   Doherty, Jennifer A ^a   Chen, Chu ^a,b,d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

DNA repair; Effect modification; Endometrial; NER; Polymorphism

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DAMAGE; ENDOMETRIUM CANCER; EXCISION REPAIR; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; OBESITY; ORAL CONTRACEPTION; PARITY; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOM SAMPLE; RISK FACTOR; SMOKING;

AGED; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; RISK FACTORS; WASHINGTON; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 33751434568     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.05.020     Document Type: Article

References (24)

1. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
2. Cavalieri E.L., Stack D.E., Devanesan P.D., et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 94 (1997) 10937-10942
3. Cavalieri E., Frenkel K., Liehr J.G., Rogan E., and Roy D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr (2000) 75-93
4. Rothman K.J., and Greenland S. Modern epidemiology (1998), Lippincott-Raven, Philadelphia
5. Weiss J.M., Weiss N.S., Ulrich C.M., Doherty J.A., Voigt L.F., and Chen C. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomark Prev 14 (2005) 2524-2530
6. Doherty J.A., Weiss N.S., Freeman R.J., et al. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomark Prev 14 (2005) 357-366
7. Marchbanks P.A., McDonald J.A., Wilson H.G., et al. The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol 12 (2002) 213-221
8. Hankey B.F., Ries L.A., and Edwards B.K. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomark Prev 8 (1999) 1117-1121
9. Waksberg J. Sampling methods for random digit dialing. J Am Stat Soc 73 (1978) 40-46
10. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
11. Edman C.D., and MacDonald P.C. Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulator young women. Am J Obstet Gynecol 130 (1978) 456-461
12. MacDonald P.C., Edman C.D., Hemsell D.L., Porter J.C., and Siiteri P.K. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 130 (1978) 448-455
13. MacDonald P.C., and Siiteri P.K. The relationship between the extraglandular production of estrone and the occurrence of endometrial neoplasia. Gynecol Oncol 2 (1974) 259-263
14. Davidson B.J., Gambone J.C., Lagasse L.D., et al. Free estradiol in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab 52 (1981) 404-408
15. Kaye S.A., Folsom A.R., Soler J.T., Prineas R.J., and Potter J.D. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 20 (1991) 151-156
16. Nyholm H.C., Nielsen A.L., Lyndrup J., Dreisler A., Hagen C., and Haug E. Plasma oestrogens in postmenopausal women with endometrial cancer. Br J Obstet Gynaecol 100 (1993) 1115-1119
17. Cook L.S., Doherty J.A., Weiss N.S., and Chen C. Endometrial cancer: epidemiology and molecular endocrinology. In: Henderson B.E., Ponder B., and Ross R.K. (Eds). Hormones, genes, and cancer (2003), Oxford University Press, Inc., New York 371-397
18. Cook L.S., and Weiss N.S. Endometrial cancer. In: Goldman M.B., and Hatch M.C. (Eds). Women and health (1999), Academic Press, London 916-931
19. Grady D., and Ernster V.L. Endometrial cancer. In: Schottenfeld D., and Fraumeni J.F. (Eds). Cancer epidemiology and prevention (1996), Oxford University Press, New York, NY 1058-1089
20. Voigt L.F., and Weiss N.S. Epidemiology of endometrial cancer. Cancer Treat Res 49 (1989) 1-21
21. Austin H., Drews C., and Partridge E.E. A case-control study of endometrial cancer in relation to cigarette smoking, serum estrogen levels, and alcohol use. Am J Obstet Gynecol 169 (1993) 1086-1091
22. Brinton L.A., Barrett R.J., Berman M.L., Mortel R., Twiggs L.B., and Wilbanks G.D. Cigarette smoking and the risk of endometrial cancer. Am J Epidemiol 137 (1993) 281-291
23. Key T.J., Pike M.C., Brown J.B., Hermon C., Allen D.S., and Wang D.Y. Cigarette smoking and urinary oestrogen excretion in premenopausal and post-menopausal women. Br J Cancer 74 (1996) 1313-1316
24. Michnovicz J.J., Hershcopf R.J., Naganuma H., Bradlow H.L., and Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 315 (1986) 1305-1309